 Insmed Incorporated Nasdaq: INSM announced today that it priced a registered underwritten public offering of 9,700,000 shares of its common stock at a price to the public of 23.25 per share. The gross proceeds to Insmed from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Insmed, are expected to be approximately 225.5 million. In addition, Insmed has granted the underwriters a 30-day option to purchase up to an additional 1,455,000 shares of common stock. 